EUVIMEDEUVIMED entdecken
KorrekturOpen Access

HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway: Am J Cancer Res. 2023; 13(7): 3013-3026

Meng Jia, Kai-Yi Zhou, Li-Jia Deng, Sheng Fang

American Journal of Cancer Research · 2026 · 16 (7) · 3193-3197

DOI: 10.62347/yexz3177 ↗

Kurz gefasst

Korrektur in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Meng Jia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University Chongqing, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University Chongqing, China.

Zitieren

APA

Jia, M., Zhou, K. Y., Deng, L. J., & Fang, S. (2026). HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway: Am J Cancer Res. 2023; 13(7): 3013-3026. American Journal of Cancer Research, 16(7), 3193-3197. https://doi.org/10.62347/yexz3177

Vancouver

Jia M, Zhou KY, Deng LJ, Fang S. HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway: Am J Cancer Res. 2023; 13(7): 3013-3026. American Journal of Cancer Research. 2026;16(7):3193-3197. doi:10.62347/yexz3177

BibTeX
@article{Jia2026,
  author = {Jia, Meng and Zhou, Kai-Yi and Deng, Li-Jia and Fang, Sheng},
  title = {HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway: Am J Cancer Res. 2023; 13(7): 3013-3026},
  journal = {American Journal of Cancer Research},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {3193--3197},
  doi = {10.62347/yexz3177}
}
Kostenlos starten →